1. AB0209 Retrospective analysis of rheumatoid arthritis patients complicated with mtx-related lymphoproliferative diseases. (23rd January 2014) Authors: Okuyama, A.; Nagasawa, H.; Kondo, T.; Nishi, E.; Takei, H.; Sakai, R.; Chino, K.; Shibata, A.; Amano, K. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A850 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0497 The Euro-Lupus Protocol plus Tacrolimus for Lupus Nephritis: Potentiality of Multi-Target Therapy. (10th June 2014) Authors: Sakai, R.; Shibata, A.; Chino, K.; Okuyama, A.; Kondo, T.; Nishi, E.; Takei, H.; Nagasawa, H.; Amano, K. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 971 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0549 Discontinuation of methotrexate (MTX) in rheuamtoid arthritis (RA) patients receiving tocilizumab (TCZ). (23rd January 2014) Authors: Nishimura, K.; Sakai, R.; Kondo, T.; Kurasawa, T.; Okuyama, A.; Nishi, E.; Shirai, Y.; Takei, H.; Nagasawa, H.; Amano, K. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0586 104-weeks assessments of clinical and structural remission in rheumatoid arthritis patients with tocilizumab from the reaction study. (23rd January 2014) Authors: Tanaka, Y.; Takeuchi, T.; Amano, K.; Sato, E.; Nawata, M.; Nagasawa, H.; Hoshi, D.; Saito, K.; Fukuyo, S.; Hanami, K.; Kameda, H.; Kurasawa, T.; Kaneko, Y.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Histological detection of catalytic ferrous iron with the selective turn-on fluorescent probe RhoNox-1 in a Fenton reaction-based rat renal carcinogenesis model*. (September 2014) Authors: Mukaide, T.; Hattori, Y.; Misawa, N.; Funahashi, S.; Jiang, L.; Hirayama, T.; Nagasawa, H.; Toyokuni, S. Journal: Free radical research Issue: Volume 48:Number 9(2014:Sep.) Page Start: 990 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Histological detection of catalytic ferrous iron with the selective turn-on fluorescent probe RhoNox-1 in a Fenton reaction-based rat renal carcinogenesis model*. (September 2014) Authors: Mukaide, T.; Hattori, Y.; Misawa, N.; Funahashi, S.; Jiang, L.; Hirayama, T.; Nagasawa, H.; Toyokuni, S. Journal: Free radical research Issue: Volume 48:Number 9(2014:Sep.) Page Start: 990 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0140 Effectiveness of Abatacept Against Rheumatoid Arthritis in Daily Clinical Practice - Orbit Study. (23rd January 2014) Authors: Takeuchi, T.; Tanaka, Y.; Amano, K.; Kikuchi, J.; Tanaka, E.; Hirata, S.; Nagasawa, H.; Yasuoka, H.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0257 Clinical and Radiographic Effects after 52-Week of Adding Tocilizumab or Switching to Tocilizumab in RA Patients with Inadequate Response to Methotrexate: Results from A Prospective Randomized Controlled Study (Surprise Study). (10th June 2014) Authors: Takeuchi, T.; Kaneko, Y.; Atsumi, T.; Tanaka, Y.; Inoh, M.; Kobayashi, H.; Amano, K.; Miyata, M.; Murakawa, Y.; Fujii, T.; Kawakami, A.; Yamanaka, H.; Yamamoto, K.; Miyasaka, N.; Mimori, T.; Tanaka, E.; Nagasawa, H.; Yasuoka, H.; Hirata, S. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. THU0155 The addition of another disease-modifying anti-rheumatic drug to methotrexate in place of infliximab improves the rate of infliximab-free sustained remission. (23rd January 2014) Authors: Kurasawa, T.; Nagasawa, H.; Amano, K.; Takeuchi, T.; Kameda, H. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗